下表是 44 种技术信号在个股级别的历史回测:每个(信号,个股)组合独立计算胜率,只保留胜率 > 70% 的。样本数越多,胜率越可信。
2026-10-21 重算:三个回测组合(会员可见)按修正后的输入重建,下表随之更新。修正有四处:只计入在触发后下一根K线入场的历史结果(A股剔除了约 5.8 万条入场错位的旧结果);胜率相同时按已知结果更多、再按成交额排序(此前实际按信号名的字母顺序);按除权因子复权后的日线交易(此前未复权,送转股被当成亏损);港股改用信号所用的原始行情序列。三个组合仍跟随 2026-10-15 选定的变体——美股 逆向·最差MAE+MFE目标,A股 逆向·最低胜率+MFE目标,港股 逆向·成交额+跟踪15%。这个选择是在同一区间内事后做出的;2026-10-20 的对照研究发现,它与在同日已判定的信号中随机挑选没有可区分的差别,各变体的排名也逐年不稳定。所以它不是“最好的”策略,保留它只为让组合有一条连续的历史。按修正后的输入,美股为 +277.3%(10-15 版 +195.8%),A股 −24.3%(原 +27.2%),港股 −11.7%(原 +49.4%)。2026-10-11 更正:此前公布的收益率(如美股 +419.9%)使用了未来数据,现已作废。问题有两处:先按全部历史的胜率挑选(信号,个股),等于只留下后来赢了的;又把结果尚未出来的更早触发算进胜率和目标价。下表为去除这两处之后的结果。
规则:某(信号,个股)在信号日当时已知的10日胜率 > 70%(至少3次已走完的历史触发;尚未走完10日的更早触发不计入),且信号日成交额 > 1亿本币;次日开盘买入25%仓位,最多4个持仓。退出:历史最优MFE目标价(10日),或跟踪止损(10% / 15% / 20%);浮盈达10%后止损上移到成本价。单笔止损为买入时账户净值的2%。已剔除信号日涨停、上市首日(A股),北交所按30%涨停判断。
逆向:同样的规则和区间,只把条件反过来——当时已知的10日胜率 < 30%(至少3次已走完的触发),按最低胜率、最差MAE或成交额排序。表中顺势与逆向的24种组合放在一起,可按任一列排序。
回测区间:美股 2024-10-01 → 2026-10-21;A股 2024-10-08 → 2026-10-21;港股 2024-10-02 → 2026-10-21
| 市场 | 策略 | 区间 | 排序 | 退出 | 交易数 | 胜率 | 平均每笔 | 收益率 | 最大回撤 |
|---|---|---|---|---|---|---|---|---|---|
| 美股 | 逆向 <30% | 2024-10-01 → 2026-10-21 | 最差MAE | MFE目标 | 156 | 19.6% | +4.14% | +277.3% | -36.9% |
| 美股 | 顺势 >70% | 2024-10-01 → 2026-10-21 | MFE潜力 | 跟踪20% | 75 | 22.5% | +4.34% | +101.8% | -29.4% |
| 美股 | 顺势 >70% | 2024-10-01 → 2026-10-21 | 胜率 | 跟踪15% | 57 | 30.2% | +5.80% | +98.9% | -19.4% |
| 美股 | 顺势 >70% | 2024-10-01 → 2026-10-21 | 胜率 | MFE目标 | 98 | 38.9% | +2.46% | +81.9% | -17.1% |
| 美股 | 逆向 <30% | 2024-10-01 → 2026-10-21 | 成交额 | 跟踪20% | 62 | 15.5% | +1.48% | +79.8% | -36.3% |
| 美股 | 逆向 <30% | 2024-10-01 → 2026-10-21 | 最差MAE | 跟踪20% | 139 | 16.9% | +2.54% | +49.8% | -43.7% |
| A股 | 顺势 >70% | 2024-10-08 → 2026-10-21 | 胜率 | 跟踪10% | 179 | 34.3% | +1.26% | +48.5% | -39.6% |
| 美股 | 顺势 >70% | 2024-10-01 → 2026-10-21 | 成交额 | 跟踪15% | 26 | 31.8% | +5.19% | +36.2% | -13.5% |
| 美股 | 顺势 >70% | 2024-10-01 → 2026-10-21 | MFE潜力 | 跟踪10% | 191 | 32.1% | +0.62% | +31.5% | -29.9% |
| 美股 | 逆向 <30% | 2024-10-01 → 2026-10-21 | 成交额 | 跟踪15% | 64 | 23.3% | -0.11% | +30.8% | -32.2% |
| A股 | 逆向 <30% | 2024-10-08 → 2026-10-21 | 最差MAE | MFE目标 | 110 | 17.9% | +1.50% | +30.5% | -31.0% |
| 美股 | 顺势 >70% | 2024-10-01 → 2026-10-21 | 成交额 | MFE目标 | 67 | 31.7% | +1.74% | +30.3% | -25.8% |
| 美股 | 逆向 <30% | 2024-10-01 → 2026-10-21 | 成交额 | 跟踪10% | 152 | 34.9% | +0.53% | +27.2% | -30.8% |
| A股 | 逆向 <30% | 2024-10-08 → 2026-10-21 | 最低胜率 | 跟踪10% | 151 | 36.1% | +0.65% | +19.3% | -23.1% |
| 美股 | 逆向 <30% | 2024-10-01 → 2026-10-21 | 最低胜率 | 跟踪20% | 97 | 15.1% | +0.65% | +17.8% | -39.7% |
| 美股 | 顺势 >70% | 2024-10-01 → 2026-10-21 | 胜率 | 跟踪10% | 91 | 32.2% | +0.46% | +16.4% | -23.6% |
| 美股 | 顺势 >70% | 2024-10-01 → 2026-10-21 | MFE潜力 | 跟踪15% | 126 | 27.0% | +0.51% | +14.5% | -38.1% |
| 美股 | 顺势 >70% | 2024-10-01 → 2026-10-21 | 成交额 | 跟踪20% | 16 | 8.3% | -1.19% | +8.2% | -14.1% |
| A股 | 顺势 >70% | 2024-10-08 → 2026-10-21 | 成交额 | 跟踪20% | 93 | 16.7% | +0.70% | +6.9% | -48.8% |
| A股 | 逆向 <30% | 2024-10-08 → 2026-10-21 | 成交额 | 跟踪10% | 208 | 34.1% | +0.29% | +4.0% | -33.9% |
| 美股 | 顺势 >70% | 2024-10-01 → 2026-10-21 | 胜率 | 跟踪20% | 50 | 10.9% | +0.43% | +3.3% | -36.1% |
| A股 | 顺势 >70% | 2024-10-08 → 2026-10-21 | MFE潜力 | 跟踪15% | 123 | 24.4% | +0.67% | +3.0% | -35.1% |
| 港股 | 顺势 >70% | 2024-10-02 → 2026-10-21 | MFE潜力 | 跟踪20% | 154 | 18.5% | +0.06% | +1.1% | -51.4% |
| A股 | 顺势 >70% | 2024-10-08 → 2026-10-21 | 成交额 | 跟踪10% | 159 | 36.9% | +0.20% | -0.9% | -38.3% |
| 港股 | 顺势 >70% | 2024-10-02 → 2026-10-21 | 成交额 | 跟踪15% | 186 | 23.6% | -0.18% | -7.4% | -36.5% |
| A股 | 逆向 <30% | 2024-10-08 → 2026-10-21 | 最差MAE | 跟踪15% | 100 | 29.2% | -0.11% | -7.6% | -35.7% |
| A股 | 逆向 <30% | 2024-10-08 → 2026-10-21 | 最差MAE | 跟踪20% | 89 | 15.3% | -0.59% | -9.7% | -28.0% |
| 美股 | 逆向 <30% | 2024-10-01 → 2026-10-21 | 成交额 | MFE目标 | 173 | 29.6% | -0.41% | -10.9% | -30.8% |
| 美股 | 顺势 >70% | 2024-10-01 → 2026-10-21 | MFE潜力 | MFE目标 | 152 | 10.8% | -0.65% | -11.7% | -52.3% |
| 港股 | 逆向 <30% | 2024-10-02 → 2026-10-21 | 成交额 | 跟踪15% | 179 | 24.0% | +0.11% | -11.7% | -42.2% |
| 港股 | 逆向 <30% | 2024-10-02 → 2026-10-21 | 最低胜率 | 跟踪20% | 117 | 19.5% | -0.43% | -13.5% | -49.7% |
| 港股 | 顺势 >70% | 2024-10-02 → 2026-10-21 | 成交额 | 跟踪20% | 136 | 16.5% | -0.57% | -14.5% | -51.6% |
| A股 | 顺势 >70% | 2024-10-08 → 2026-10-21 | MFE潜力 | 跟踪20% | 112 | 14.7% | -0.30% | -14.9% | -41.7% |
| A股 | 顺势 >70% | 2024-10-08 → 2026-10-21 | MFE潜力 | MFE目标 | 92 | 4.5% | -0.38% | -15.5% | -43.5% |
| A股 | 逆向 <30% | 2024-10-08 → 2026-10-21 | 最低胜率 | 跟踪20% | 98 | 16.0% | -0.56% | -15.8% | -46.4% |
| 港股 | 逆向 <30% | 2024-10-02 → 2026-10-21 | 最低胜率 | 跟踪10% | 248 | 31.1% | -0.08% | -15.8% | -47.8% |
| A股 | 逆向 <30% | 2024-10-08 → 2026-10-21 | 成交额 | 跟踪15% | 133 | 21.5% | -0.17% | -16.1% | -39.5% |
| 美股 | 顺势 >70% | 2024-10-01 → 2026-10-21 | 成交额 | 跟踪10% | 67 | 22.2% | -1.59% | -18.7% | -28.7% |
| A股 | 逆向 <30% | 2024-10-08 → 2026-10-21 | 最低胜率 | 跟踪15% | 130 | 26.2% | -0.34% | -19.1% | -49.7% |
| 港股 | 逆向 <30% | 2024-10-02 → 2026-10-21 | 最差MAE | 跟踪15% | 197 | 23.3% | -0.04% | -21.0% | -49.8% |
| 港股 | 顺势 >70% | 2024-10-02 → 2026-10-21 | 胜率 | 跟踪15% | 213 | 25.7% | -0.18% | -22.0% | -47.3% |
| 港股 | 逆向 <30% | 2024-10-02 → 2026-10-21 | 最低胜率 | 跟踪15% | 167 | 27.0% | -0.44% | -22.6% | -43.6% |
| 港股 | 顺势 >70% | 2024-10-02 → 2026-10-21 | 胜率 | 跟踪20% | 159 | 17.9% | -0.59% | -22.7% | -56.5% |
| 港股 | 顺势 >70% | 2024-10-02 → 2026-10-21 | MFE潜力 | MFE目标 | 156 | 9.2% | -0.82% | -24.2% | -55.0% |
| A股 | 逆向 <30% | 2024-10-08 → 2026-10-21 | 最低胜率 | MFE目标 | 204 | 37.5% | -0.38% | -24.3% | -31.3% |
| 美股 | 逆向 <30% | 2024-10-01 → 2026-10-21 | 最低胜率 | 跟踪10% | 134 | 32.3% | -0.60% | -25.7% | -39.1% |
| 港股 | 逆向 <30% | 2024-10-02 → 2026-10-21 | 成交额 | 跟踪10% | 248 | 33.5% | -0.40% | -27.8% | -41.1% |
| 港股 | 逆向 <30% | 2024-10-02 → 2026-10-21 | 最差MAE | 跟踪20% | 177 | 16.2% | -0.41% | -29.3% | -45.2% |
| 港股 | 逆向 <30% | 2024-10-02 → 2026-10-21 | 成交额 | 跟踪20% | 107 | 21.9% | -1.55% | -30.3% | -41.7% |
| A股 | 逆向 <30% | 2024-10-08 → 2026-10-21 | 成交额 | 跟踪20% | 114 | 16.2% | -1.20% | -32.6% | -45.4% |
| 港股 | 顺势 >70% | 2024-10-02 → 2026-10-21 | MFE潜力 | 跟踪15% | 211 | 24.0% | -0.63% | -32.7% | -49.1% |
| 港股 | 顺势 >70% | 2024-10-02 → 2026-10-21 | 胜率 | 跟踪10% | 269 | 31.6% | -0.38% | -32.8% | -40.4% |
| 美股 | 逆向 <30% | 2024-10-01 → 2026-10-21 | 最差MAE | 跟踪15% | 182 | 26.8% | -0.84% | -33.6% | -50.0% |
| 港股 | 顺势 >70% | 2024-10-02 → 2026-10-21 | 胜率 | MFE目标 | 178 | 10.9% | -0.56% | -33.8% | -54.1% |
| A股 | 顺势 >70% | 2024-10-08 → 2026-10-21 | 成交额 | MFE目标 | 123 | 12.4% | -1.38% | -34.6% | -50.7% |
| 港股 | 顺势 >70% | 2024-10-02 → 2026-10-21 | 成交额 | MFE目标 | 168 | 10.3% | -0.90% | -35.4% | -50.9% |
| A股 | 顺势 >70% | 2024-10-08 → 2026-10-21 | 胜率 | MFE目标 | 128 | 14.5% | -1.16% | -35.9% | -56.7% |
| A股 | 逆向 <30% | 2024-10-08 → 2026-10-21 | 最差MAE | 跟踪10% | 154 | 34.7% | -1.33% | -37.0% | -44.3% |
| A股 | 逆向 <30% | 2024-10-08 → 2026-10-21 | 成交额 | MFE目标 | 130 | 20.5% | -1.84% | -37.0% | -40.6% |
| A股 | 顺势 >70% | 2024-10-08 → 2026-10-21 | MFE潜力 | 跟踪10% | 218 | 34.6% | -0.78% | -37.1% | -47.7% |
| 港股 | 逆向 <30% | 2024-10-02 → 2026-10-21 | 成交额 | MFE目标 | 167 | 20.1% | -0.63% | -37.5% | -47.5% |
| 港股 | 逆向 <30% | 2024-10-02 → 2026-10-21 | 最低胜率 | MFE目标 | 217 | 28.5% | -0.70% | -38.3% | -59.7% |
| A股 | 顺势 >70% | 2024-10-08 → 2026-10-21 | 成交额 | 跟踪15% | 112 | 20.2% | -1.40% | -39.6% | -51.1% |
| 美股 | 逆向 <30% | 2024-10-01 → 2026-10-21 | 最差MAE | 跟踪10% | 286 | 29.2% | -0.51% | -42.0% | -52.7% |
| 美股 | 逆向 <30% | 2024-10-01 → 2026-10-21 | 最低胜率 | MFE目标 | 217 | 33.3% | -1.12% | -43.2% | -54.9% |
| 港股 | 逆向 <30% | 2024-10-02 → 2026-10-21 | 最差MAE | 跟踪10% | 314 | 30.2% | -0.58% | -44.4% | -53.1% |
| 港股 | 顺势 >70% | 2024-10-02 → 2026-10-21 | MFE潜力 | 跟踪10% | 318 | 32.1% | -0.63% | -46.0% | -63.8% |
| 港股 | 顺势 >70% | 2024-10-02 → 2026-10-21 | 成交额 | 跟踪10% | 276 | 30.1% | -0.88% | -48.4% | -54.0% |
| 港股 | 逆向 <30% | 2024-10-02 → 2026-10-21 | 最差MAE | MFE目标 | 176 | 16.2% | -1.25% | -52.3% | -66.6% |
| A股 | 顺势 >70% | 2024-10-08 → 2026-10-21 | 胜率 | 跟踪20% | 103 | 14.1% | -3.40% | -54.2% | -62.1% |
| 美股 | 逆向 <30% | 2024-10-01 → 2026-10-21 | 最低胜率 | 跟踪15% | 117 | 19.5% | -2.67% | -55.2% | -59.3% |
| A股 | 顺势 >70% | 2024-10-08 → 2026-10-21 | 胜率 | 跟踪15% | 120 | 24.1% | -2.81% | -56.9% | -58.9% |
未计交易成本。日线按除权因子复权(A股、港股乘法复权,美股本身已复权);成交额条件仍按实际成交额判断。2026-10-21 按更正后的信号数据与修正后的输入重算。24种组合在三个市场之间没有一致的赢家,排名随输入的小改动大幅变化;对照研究(随机挑选、逐年滚动选择)表明,表中任何一个变体都不构成有效性的证据。